<

 
Data updated 2025-05-14 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date19842049.9 (espacenet)  (Federated)  (European Patent Register), 20190722
Patent/reg. no. and dateDK/EP 3823617, 20240306
Publication date20210526
Priority no. and dateUS 201862701726 P, 20180721
EP pub. no. and date EP 3823617 20210526
Effective date
Applicant/ownerLinnaeus Therapeutics, Inc., 30 Washington Ave Suite F
Haddonfield NJ 08033, US
Applicant ref. no.1697167
InventorNATALE, Christopher, 717 S 19th Street, Apt. 2
Philadelphia, Pennsylvania 19146, US,
MOONEY, Patrick, 625 Clinton Ave.
Haddonfield, New Jersey 08033, US,
GARYANTES, Tina, 18 Roberts Rd.
Warren, New Jersey 07059, US,
LUKE, Wayne, 208 Jennings Street West
Lafayette, Indiana 47906, US
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB, GB
Opponent
IPC ClassA61K 31/47 (2006.01) , A61P 35/00 (2006.01) , C07C 309/19 (2006.01) , C07C 309/29 (2006.01) , C07C 309/35 (2006.01) , C07D 405/04 (2006.01) 
TitleENANTIOMERT OPRENSET GPER-AGONIST TIL ANVENDELSE VED BEHANDLING AF SYGDOMSTILSTANDE OG SYGDOMME
Int. application no.US2019042827
Int. publication no.WO2020023391
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact